γ-tocopherol, but not α-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats

FASEB Journal

Volumn 17, Issue 8, 2003, Pages 816-822

  Jiang, Qing ^b   Ames, Bruce N ^a  

^a CHORI   (United States)

^b NONE

Author keywords

tocopherol metabolite; Leukotriene B4; Prostaglandin E2; TNF alpha; Vitamin E

Indexed keywords

2,7,8 TRIMETHYL 2 (BETA CARBOXYETHYL) 6 HYDROXYCHROMAN; 8 ISOPROSTANE; ALPHA TOCOPHEROL; ARACHIDONATE 5 LIPOXYGENASE; GAMMA TOCOPHEROL; ICOSANOID; ISOPROSTANE DERIVATIVE; LACTATE DEHYDROGENASE; LEUKOTRIENE B4; NITRATE; NITRITE; PROSTAGLANDIN E2; TOCOPHEROL DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FOOD INTAKE; INFLAMMATION; LIPID PEROXIDATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; TREATMENT OUTCOME;

ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; CARRAGEENAN; CHROMANS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; EICOSANOIDS; EXUDATES AND TRANSUDATES; GAMMA-TOCOPHEROL; INFLAMMATION; LEUKOTRIENE B4; LIPID PEROXIDATION; MALE; NEUTROPHIL INFILTRATION; NITRATES; NITRITES; PROPIONIC ACIDS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0038375011     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.02-0877com     Document Type: Article

References (39)

1. Balkwill, F., and Mantovani, A. (2001) Inflammation and cancer: back to Virchow? Lancet 357, 539-545
2. Libby, P., Ridker, P. M., and Maseri, A. (2002) Inflammation and atherosclerosis. Circulation 105, 1135-1143
3. McGeer, P. L., and McGeer, E. G. (2001) Inflammation, autotoxicity and Alzheimer disease. Neurobiol. Aging 22, 799-809
4. Vane, J. R. (1976) Prostaglandins as mediators of inflammation. Adv. Prostaglandin Thromboxane Res. 2, 791-801
5. Samad, T. A., Moore, K. A., Sapirstein, A., Billet, S., Allchorne, A., Poole, S., Bonventre, J. V., and Woolf, C. J. (2001) Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature (London) 410, 471-475
6. Williams, J. A., and Shacter, E. (1997) Regulation of macrophage cytokine production by prostaglandin E2. Distinct roles of cyclooxygenase-1 and -2. J. Biol. Chem. 272, 25693-25699
7. Vane, J. R., and Botting, R. M. (1998) Mechanism of action of antiinflammatory drugs. Int. J. Tissue React. 20, 3-15
8. Yokomizo, T., Izumi, T., and Shimizu, T. (2001) Leukotriene B4: metabolism and signal transduction. Arch. Biochem. Biophys. 385, 231-241
9. Wynne, H. A., and Campbell, M. (1993) Pharmacoeconomics of nonsteroidal anti-inflammatory drugs (NSAIDs). Pharmacoeconomics 3, 107-123
10. Jiang, Q., Elson-Schwab, I., Courtemanche, C., and Ames, B. N. (2000) gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl. Acad. Sci. USA 97, 11494-11499
11. Sedgwick, A. D., and Lees, P. (1986) Studies of eicosanoid production in the air pouch model of synovial inflammation. Agents Actions 18, 429-438
12. Jiang, Q., Lykkesfeldt, J., Shigenaga, M. K., Shigeno, E. T., Christen, S., and Ames, B. N. (2002) gamma-Tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation. Free Radic. Biol. Med. 33, 1534-1542
13. Stahl, W., Graf, P., Brigelius-Flohe, R., Wechter, W., and Sies, H. (1999) Quantification of the alpha- and gamma-tocopherol metabolites 2,5,7, 8-tetramethyl-2-(2′-carboxyethyl)-6-hydroxychroman and 2,7, 8-trimethyl-2-(2′-carboxyethyl)-6-hydroxychroman in human serum. Anal. Biochem. 275, 254-259
14. Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., and Seibert, K. (1994) Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA 91, 3228-3232
15. Sedgwick, A. D., Sin, Y. M., Edwards, J. C., and Willoughby, D. A. (1983) Increased inflammatory reactivity in newly formed lining tissue. J. Pathol. 141, 483-495
16. Murray, E. D., Jr., Wechter, W. J., Kantoci, D., Wang, W. H., Pham, T., Quiggle, D. D., Gibson, K. M., Leipold, D., and Anner, B. M. (1997) Endogenous natriuretic factors 7: biospecificity of a natriuretic gamma-tocopherol metabolite LLU-alpha. J. Pharmacol. Exp. Ther. 282, 657-662
17. Morrow, J. D. (2000) The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab. Rev. 32, 377-385
18. Jiang, Q., Christen, S., Shigenaga, M. K., and Ames, B. N. (2001) gamma-tocopherol, the major form of vitamin E in the U.S. diet, deserves more attention. Am. J. Clin. Nutr. 74, 714-722
19. Cooney, R. V., Franke, A. A., Harwood, P. J., Hatch-Pigott, V., Custer, L. J., and Mordan, L. J. (1993) Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol. Proc. Natl. Acad. Sci. USA 90, 1771-1775
20. Cooney, R. V., Harwood, P. J., Franke, A. A., Narala, K., Sundstrom, A. K., Berggren, P. O., and Mordan, L. J. (1995) Products of gamma-tocopherol reaction with NO2 and their formation in rat insulinoma (RINm5F) cells. Free Radic. Biol. Med. 19, 259-269
21. Christen, S., Woodall, A. A., Shigenaga, M. K., Southwell-Keely, P. T., Duncan, M. W., and Ames, B. N. (1997) gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc. Natl. Acad. Sci. USA 94, 3217-3222
22. Williamson, K. S., Prasad Gabbita, S., Mou, S., West, M., Pye, Q. N., Markesbery, W. R., Cooney, R. V., Grammas, P., Reimann Philipp, U., Floyd, R. A., et al. (2002) The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide 6, 221-227
23. Beharka, A. A., Wu, D., Serafini, M., and Meydani, S. N. (2002) Mechanism of vitamin E inhibition of cyclooxygenase activity in macrophages from old mice: role of peroxynitrite. Free Radic. Biol. Med. 32, 503-511
24. Landino, L. M., Crews, B. C., Timmons, M. D., Morrow, J. D., and Marnett, L. J. (1996) Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc. Natl. Acad. Sci. USA 93, 15069-15074
25. Belardelli, F. (1995) Role of interferons and other cytokines in the regulation of the immune response. APMIS 103, 161-179
26. Criscione, L. G., and St. Clair, E. W. (2002) Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases. Curr. Opin. Rheumatol. 14, 204-211
27. Lorenz, H. M., and Kalden, J. R. (2002) Perspectives for TNF-alpha-targeting therapies. Arthritis Res. 4, S17-S24
28. Kirchner, T., Argentieri, D. C., Barbone, A. G., Singer, M., Steber, M., Ansell, J., Beers, S. A., Wachter, M. P., Wu, W., Malloy, E., et al. (1997) Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation. J. Pharmacol. Exp. Ther. 282, 1094-1101
29. Yin, M. J., Yamamoto, Y., and Gaynor, R. B. (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature (London) 396, 77-80
30. Cronstein, B. N., Montesinos, M. C., and Weissmann, G. (1999) Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc. Natl. Acad. Sci. USA 96, 6377-6381
31. Swanson, J. E., Ben, R. N., Burton, G. W., and Parker, R. S. (1999) Urinary excretion of 2,7, 8-trimethyl-2-(beta-carboxy-ethyl)-6-hydroxychroman is a major route of elimination of gamma-tocopherol in humans. J. Lipid Res. 40, 665-671
32. Marnett, L. J. (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 52, 5575-5589
33. Smalley, W. E., and DuBois, R. N. (1997) Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv. Pharmacol. 39, 1-20
34. Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., and Heath, C. W., Jr. (1993) Aspirin use and risk of fatal cancer. Cancer Res. 53, 1322-1327
35. Helzlsouer, K. J., Huang, H. Y., Alberg, A. J., Hoffman, S., Burke, A., Norkus, E. P., Morris, J. S., and Comstock, G. W. (2000) Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J. Natl. Cancer Inst. 92, 2018-2023
36. Plutzky, J. (2001) Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am. J. Cardiol. 88, 10K-15K
37. Kristenson, M., Zieden, B., Kucinskiene, Z., Elinder, L. S., Bergdahl, B., Elwing, B., Abaravicius, A, Razinkoviene, L., Calkauskas, H., and Olsson, A. G. (1997) Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50. BMJ 314, 629-633
38. Ohrvall, M., Sundlof, G., and Vessby, B. (1996) Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J. Intern. Med. 239, 111-117
39. Sabate, J. (1999) Nut consumption, vegetarian diets, ischemic heart disease risk, and all- cause mortality: evidence from epidemiologic studies. Am. J. Clin. Nutr. 70, 500S-503S